Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Jann‐Tay Wang(National Taiwan University Hospital), Pan‐Chyr Yang(Institute of Biomedical Sciences, Academia Sinica), Chong‐Jen Yu(National Taiwan University Hospital), Shan‐Chwen Chang(National Taiwan University Hospital), Chi‐Tai Fang(National Taiwan University), Wang‐Huei Sheng(National Taiwan University Hospital), Yee‐Chun Chen(National Taiwan University Hospital), Jiun‐Ling Wang(National Taiwan University Hospital)
Cited by 229
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|The Lancet Oncology|2015|980
A Novel Virulence Gene in <i>Klebsiella pneumoniae</i> Strains Causing Primary Liver Abscess and Septic Metastatic Complications
|The Journal of Experimental Medicine|2004|779
Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae
|Journal of Clinical Microbiology|2018|775